The U.S. Food and Drug Administration (FDA) announced on February 28th that the prescribing information for cholesterol reducing drugs in the statin class will include warnings about the risk of increased blood sugar levels, HbA1c, and diagnoses of diabetes.
Drugs in the statin class include:
- Lipitor (atorvastatin)
- Lescol (fluvastatin)
- Mevacor (lovastatin)
- Altoprev (lovastatin extended-release)
- Livalo (pitavastatin)
- Pravachol (pravastatin)
- Crestor (rosuvastatin)
- Zocor (simvastatin)
Combination products that contain statins include:
- Advicor (lovastatin/niacin extended-release)
- Simcor (simvastatin/niacin extended-release)
- Vytorin (simvastatin/ezetimibe)
Continue
-
- 1
- of 3
-
For More Healthcare Insights Join Us On Twitter and Facebook. Join The Community To Publish Articles.
Copyright 2023 RxEconsult. All Rights Reserved | Privacy Policy | Terms of Use | Sitemap